Flibanserin, has been rejected twice by the FDA
Malignant melanoma is the sixth most common cancer in the UK.
China is the world's largest consumer and producer of tobacco, and smoking is woven into the fabric of Chinese culture.
The discovery is crucial in the context of drug resistance and poor turnout of new antibiotics.
Cancer bullets could cure people with no other options, study shows.
Scientists have turned pork scratchings into a nutritious low-fat super snack.
The disease-in-a-dish technology is funded by the NIH.
This is the face I grew up with, she says.
Discovery raises fears that scientists elsewhere may be unknowingly working with deadly samples.
Doctors have to encourage patients to change their lifestyle to prevent epidemic.
World No Tobacco Day 2015, marked on 31 May, is calling for an end to illicit tobacco trade
Psychoactive Substances Bill will ban the supply and sale of legal highs or synthetic highs in UK
Handling deadly bioterror agents calls for stringent protocols and training, often missing.
The study only gives a short-term result conducted on mice.
Modi will perform exercises at event to mark International Day of Yoga.
Since legislation in 2007, there has been a 14%, fall among those suffering chest infections.
NY researchers call for national database to track reactions.
Mild, wet weather is perfect storm for snake inundation.
She warned holiday operator Thomson of her severe allergies before travelling to Greece.
Scientists reactivate lost memories through technology called optogenetics.
Many crucial genes lost from Y chromosome have been preserved in other chromosomes.
In the developing regions, undernourishment has declined to 12.9% of the population.
Antimicrobial resistance is considered the biggest health threat today.
No cases yet of suspected anthrax, no risk to the public, say authorities
Competitive workforce seeking edge for long days.
Nothing can change what happened, says regretful retailer.
Epigenetic regulation of two genes helped restore respiratory function in old cell lines.
Japanese nuclear regulator clears the first reactors at Kyushu Electric Power's Sendai plant, after safety checks.
The conditions are expected to last for a day or two.
'This is the start of something really exciting', says trial leader Kevin Harrington.